- Category
- Small (2023-24)
- Udyam number
- UDYAM-AP-01-0004381

Srikar Chem & Pharma India Private Limited
About Srikar Chem & Pharma India Private Limited
Data last updated:
Srikar Chem & Pharma India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 February 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2011PTC072439. Its GSTIN is 37ABWFS7418K1Z8 (Andhra Pradesh).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.46 Cr. It is led by directors Narravula Anuradha and Geyana Narravula.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dno:2 – 133/2 Flat No:215 Nirmal Ratna Apartments Gangaram Chandanagar, Hyderabad, Telangana, India – 500050.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.6 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹16.31 Lakh (net margin 1.9%) and EBITDA of ₹43.43 Lakh (EBITDA margin 5%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.
The company has about 28 employees on its provident fund (EPFO) records.
Srikar Chem & Pharma India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-01-0004381). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Srikar Chem & Pharma India has one previous CIN (Corporate Identification Number): U24100AP2011PTC072439. The current CIN is U24100TG2011PTC072439, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2011PTC072439 | Current |
| U24100AP2011PTC072439 | Previous |
Recognitions & Rankings of Srikar Chem & Pharma India
Contact details
Srikar Chem & Pharma India Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDno:2 – 133/2 Flat No:215 Nirmal Ratna Apartments Gangaram Chandanagar, Hyderabad, Telangana, India – 500050
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Srikar Chem & Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Srikar Chem & Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Srikar Chem & Pharma India Private Limited, buy the company report.
Financials of Srikar Chem & Pharma India Private Limited
FY 2025 filings availableSrikar Chem & Pharma India Private Limited reported revenue of ₹8.6 Cr (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 11% fall in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹43.43 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.31 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Srikar Chem & Pharma India Private Limited, buy the company report.
Board of directors of Srikar Chem & Pharma India Private Limited
Srikar Chem & Pharma India has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narravula Anuradha | Director | 20 Nov 2019 | 6 Years 11 Months | Current |
| Geyana Narravula | Director | 20 Nov 2019 | 6 Years 11 Months | Current |
Peer comparison
Srikar Chem & Pharma India Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pehal Life Sciences Private Limited | ₹8.66 Cr (FY 2024) | -33.0% | Mumbai, Maharashtra, India | |||
| Waxsen Lifescience Private Limited | ₹8.64 Cr (FY 2019) | -50.0% | Mumbai, Maharashtra, India | |||
| Srikar Chem & Pharma India Private Limitedthis company | ₹8.6 Cr (FY 2024) | ₹16.31 Lakh | 1.9% | -11.0% | 28 | Hyderabad, Telangana, India |
| Zahidi Pharmaceuticals Private Limited | ₹8.6 Cr (FY 2025) | 2.0% | Umbergaon, Gujarat, India | |||
| Kaizen Research Labs India Private Limited | ₹8.6 Cr (FY 2025) | -17.0% | Chennai, Tamil Nadu, India | |||
| Rebase Lifescience Private Limited | ₹8.59 Cr (FY 2025) | 8.0% | Lalpur, Gujarat, India |
To see the full peer comparison of Srikar Chem & Pharma India Private Limited, buy the company report.
Auditor
Srikar Chem & Pharma India Private Limited is audited by S T MOHITE & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S T MOHITE & CO | FY 2019 | 011410S |
Shareholding
The shareholding of Srikar Chem & Pharma India Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Srikar Chem & Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Srikar Chem & Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Srikar Chem & Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Srikar Chem & Pharma India Private Limited has a workforce of 28 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 28 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 |
To see the full employee and EPFO history of Srikar Chem & Pharma India Private Limited, buy the company report.
GST
Srikar Chem & Pharma India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37ABWFS7418K1Z8 | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Srikar Chem & Pharma India Private Limited, buy the company report.
Recent activity
Srikar Chem & Pharma India Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Geyana Narravula was appointed as Director on 20 Nov 2019.
Frequently asked questions
Srikar Chem & Pharma India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 February 2011 (15+ years old) and is registered under CIN U24100TG2011PTC072439.
Srikar Chem & Pharma India has 2 current directors:
- Narravula Anuradha - Director
- Geyana Narravula - Director
The latest financial statements of Srikar Chem & Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Srikar Chem & Pharma India is 37ABWFS7418K1Z8, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Srikar Chem & Pharma India is U24100TG2011PTC072439. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srikar Chem & Pharma India was incorporated on 01 February 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Srikar Chem & Pharma India by revenue are Pehal Life Sciences Private Limited, Waxsen Lifescience Private Limited, Zahidi Pharmaceuticals Private Limited, Kaizen Research Labs India Private Limited, Rebase Lifescience Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Geyana Narravula was appointed as Director on 20 Nov 2019. Narravula Anuradha was appointed as Director on 20 Nov 2019. Narravula Ranganayakulu ceased to be Director on 19 Nov 2019. Srikar Chem & Pharma India has 7 board changes on record in total.
Yes, Srikar Chem & Pharma India is registered as a small enterprise under Udyam registration (number: UDYAM-AP-01-0004381).
The registered office of Srikar Chem & Pharma India is at Dno:2 – 1332 Flat No:215 Nirmal Ratna Apartments Gangaram Chandanagar, Hyderabad, Telangana, India – 500050.
Srikar Chem & Pharma India operates in the pharma industry, in the drug formulation and development segment.

